Are you ready to turn groundbreaking research into tangible benefits for patients?
Then join GeneNovate®2027!
The first nationwide startup program in Germany designed to support innovators and entrepreneurs in the fields of gene and cell therapies (GCT), biotechnology, and medicine. It is aimed at early-career scientists and physicians—such as advanced undergraduates, doctoral candidates, and postdocs—but is also open to experienced researchers and clinicians looking to translate their (bio)medical innovations into clinical applications.
If you’re working on the future of biotechnology, diagnostics, bioinformatics, or gene and cell therapies—now is your moment! Take part in a unique program, develop your startup mindset, collaborate with experienced mentors on bold ideas, and connect with a strong life sciences network.
More information:
https://www.nationale-strategie-gct.de/en/genenovate/entrepreneurship-program/
Apply now:
https://www.nationale-strategie-gct.de/en/genenovate/call-for-application-2027/
The onsite workshops will take place at the Leibniz JointLab in Aachen.
For any further questions, please contact: Sven Stegemann (stegemann@dwi.rwth-aachen.de)